Steroid treatments in mice do not alter the number and function of regulatory T cells, but amplify cyclophosphamide-induced autoimmune disease

Journal of Autoimmunity

Volumn 33, Issue 2, 2009, Pages 109-120

  Moraes Fontes, Maria Francisca ^a   Rebelo, Manuel ^a   Caramalho, Íris ^a   Zelenay, Santiago ^a   Bergman, Marie Louise ^a   Coutinho, António ^a   Demengeot, Jocelyne ^a  

^a INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

Author keywords

CD4+Foxp3+ regulatory T cells; EAE; Hydrocortisone; T cell induced colitis

Indexed keywords

CYCLOPHOSPHAMIDE; HYDROCORTISONE; MYELIN BASIC PROTEIN; PERTUSSIS TOXIN; RAPICORT; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL ISOLATION; COLITIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; IMMUNOREGULATION; IN VITRO STUDY; LOW DRUG DOSE; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTOPENIA; LYMPHOCYTOTOXICITY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; ANTI-INFLAMMATORY AGENTS; CD4 LYMPHOCYTE COUNT; COLITIS; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HOMEODOMAIN PROTEINS; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENTS; LYMPHOPENIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; T-LYMPHOCYTES, REGULATORY;

EID: 68249084528     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.03.008     Document Type: Article

References (76)

1. Hench P.S., Kendall E., Slocumb C.H., and Polley H.F. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone, compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc. Staff Meet Mayo Clin 24 (1949) 181-197
2. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 (1995) 1151-1164
3. Asano M., Toda M., Sakaguchi N., and Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 184 (1996) 387-396
4. Crispin J.C., Martinez A., and Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 21 (2003) 273-276
5. + T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 59 (2004) 198-202
6. Miyara M., Amoura Z., Parizot C., Badoual C., Dorgham K., Trad S., et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 175 (2005) 8392-8400
7. Alvarado-Sanchez B., Hernandez-Castro B., Portales-Perez D., Baranda L., Layseca-Espinosa E., Abud-Mendoza C., et al. Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 27 (2006) 110-118
8. Lin S.C., Chen K.H., Lin C.H., Kuo C.C., Ling Q.D., and Chan C.H. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest 37 (2007) 987-996
9. + T cells in patients with new-onset systemic lupus erythematosus. Ann Rheum Dis (2008)
10. Ehrenstein M.R., Evans J.G., Singh A., Moore S., Warnes G., Isenberg D.A., et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200 (2004) 277-285
11. Chen L.N., Wang C.H., Zhu P., Fan C.M., Wang Y.H., Li, et al. The changes of CD4(+) CD25(high) regulatory T cells in the course of rheumatoid arthritis and their significances. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 23 (2007) 331-334
12. + regulatory T cells in patients with multiple sclerosis. J Exp Med 199 (2004) 971-979
13. +CD25 high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur J Immunol 35 (2005) 3343-3352
14. + regulatory T-cell function and FOXP3 expression. J Neurosci Res 83 (2006) 1432-1446
15. + T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis. J Neuroimmunol 180 (2006) 178-184
16. + regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients. Clin Exp Immunol 147 (2007) 412-418
17. Haas J., Fritzsching B., Trubswetter P., Korporal M., Milkova L., Fritz B., et al. Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J Immunol 179 (2007) 1322-1330
18. +CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 123 (2008) 79-89
19. Tsai M.J., and O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63 (1994) 451-486
20. Tronche F., Kellendonk C., Reichardt H.M., and Schutz G. Genetic dissection of glucocorticoid receptor function in mice. Curr Opin Genet Dev 8 (1998) 532-538
21. Brann D.W., Hendry L.B., and Mahesh V.B. Emerging diversities in the mechanism of action of steroid hormones. J Steroid Biochem Mol Biol 52 (1995) 113-133
22. Buttgereit F., Brand M.D., and Burmester G.R. Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy. Biochem Pharmacol 58 (1999) 363-368
23. Gold R., Buttgereit F., and Toyka K.V. Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders. J Neuroimmunol 117 (2001) 1-8
24. + ions into concanavalin A-stimulated thymocytes. Biochem J 326 Pt 2 (1997) 329-332
25. Reder A.T., Thapar M., and Jensen M.A. A reduction in serum glucocorticoids provokes experimental allergic encephalomyelitis: implications for treatment of inflammatory brain disease. Neurology 44 (1994) 2289-2294
26. Bakker J.M., Kavelaars A., Kamphuis P.J., Cobelens P.M., van Vugt H.H., van Bel F., et al. Neonatal dexamethasone treatment increases susceptibility to experimental autoimmune disease in adult rats. J Immunol 165 (2000) 5932-5937
27. Stock P., Akbari O., DeKruyff R.H., and Umetsu D.T. Respiratory tolerance is inhibited by the administration of corticosteroids. J Immunol 175 (2005) 7380-7387
28. - T cells to dexamethasone-induced cell death. Eur J Immunol 34 (2004) 859-869
29. Chen X., Oppenheim J.J., Winkler-Pickett R.T., Ortaldo J.R., and Howard O.M. Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur J Immunol (2006)
30. Karagiannidis C., Akdis M., Holopainen P., Woolley N.J., Hense G., Ruckert B., et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 114 (2004) 1425-1433
31. Navarro J., Aristimuno C., Sanchez-Ramon S., Vigil D., Martinez-Gines M.L., Fernandez-Cruz E., et al. Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: differential short-term changes on corticosteroids therapy. J Neuroimmunol 176 (2006) 153-161
32. + regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome. Eur J Haematol 79 (2007) 310-316
33. + regulatory T cells. J Immunol 177 (2006) 1552-1560
34. + T regulatory cells. Eur J Immunol 36 (2006) 671-680
35. + T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood 105 (2005) 2862-2868
36. + regulatory T cells. J Immunol 177 (2006) 6603-6612
37. Harada M., and Makino S. Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia 27 (1984) 604-606
38. Yasunami R., and Bach J.F. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur J Immunol 18 (1988) 481-484
39. Barrett S.P., Toh B.H., Alderuccio F., van Driel I.R., and Gleeson P.A. Organ-specific autoimmunity induced by adult thymectomy and cyclophosphamide-induced lymphopenia. Eur J Immunol 25 (1995) 238-244
40. Goverman J., Woods A., Larson L., Weiner L.P., Hood L., and Zaller D.M. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72 (1993) 551-560
41. Lafaille J.J., Nagashima K., Katsuki M., and Tonegawa S. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78 (1994) 399-408
42. Marusic S., and Tonegawa S. Tolerance induction and autoimmune encephalomyelitis amelioration after administration of myelin basic protein-derived peptide. J Exp Med 186 (1997) 507-515
43. Waldner H., Whitters M.J., Sobel R.A., Collins M., and Kuchroo V.K. Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor. Proc Natl Acad Sci U S A 97 (2000) 3412-3417
44. Bettelli E., Pagany M., Weiner H.L., Linington C., Sobel R.A., and Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med 197 (2003) 1073-1081
45. Buttgereit F., da Silva J.A., Boers M., Burmester G.R., Cutolo M., Jacobs J., et al. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis 61 (2002) 718-722
46. Lionakis M.S., and Kontoyiannis D.P. Glucocorticoids and invasive fungal infections. Lancet 362 (2003) 1828-1838
47. + regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc Natl Acad Sci U S A 99 (2002) 8213-8218
48. Olivares-Villagomez D., Wang Y., and Lafaille J.J. Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J Exp Med 188 (1998) 1883-1894
49. Turk J.L., Parker D., and Poulter L.W. Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide. Immunology 23 (1972) 493-501
50. + T cells. J Exp Med 178 (1993) 237-244
51. + T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 5 (1993) 1461-1471
52. + T cells. Immunity 1 (1994) 553-562
53. +, CD45RBhigh T cells to SCID recipients. J Immunol 158 (1997) 3464-3473
54. + regulatory T cells. J Immunol 170 (2003) 3939-3943
55. Furtado G.C., Olivares-Villagomez D., Curotto de Lafaille M.A., Wensky A.K., Latkowski J.A., and Lafaille J.J. Regulatory T cells in spontaneous autoimmune encephalomyelitis. Immunol Rev 182 (2001) 122-134
56. + T cells that prevent spontaneous autoimmune encephalomyelitis. J Immunol 164 (2000) 5499-5507
57. Van de Keere F., and Tonegawa S. CD4(+) T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice. J Exp Med 188 (1998) 1875-1882
58. Furtado G.C., Curotto de Lafaille M.A., Kutchukhidze N., and Lafaille J.J. Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J Exp Med 196 (2002) 851-857
59. Schmidt J., Gold R., Schonrock L., Zettl U.K., Hartung H.P., and Toyka K.V. T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy. Brain 123 Pt 7 (2000) 1431-1441
60. Rothenberg E.V., Moore J.E., and Yui M.A. Launching the T-cell-lineage developmental programme. Nat Rev Immunol 8 (2008) 9-21
61. Ploner C., Schmidt S., Presul E., Renner K., Schrocksnadel K., Rainer J., et al. Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia. J Steroid Biochem Mol Biol 93 (2005) 153-160
62. Herr I., Gassler N., Friess H., and Buchler M.W. Regulation of differential pro- and anti-apoptotic signaling by glucocorticoids. Apoptosis 12 (2007) 271-291
63. Reichert R.A., Weissman I.L., and Butcher E.C. Dual immunofluorescence studies of cortisone-induced thymic involution: evidence for a major cortical component to cortisone-resistant thymocytes. J Immunol 136 (1986) 3529-3534
64. Screpanti I., Morrone S., Meco D., Santoni A., Gulino A., Paolini R., et al. Steroid sensitivity of thymocyte subpopulations during intrathymic differentiation. Effects of 17 beta-estradiol and dexamethasone on subsets expressing T cell antigen receptor or IL-2 receptor. J Immunol 142 (1989) 3378-3383
65. Sentman C.L., Shutter J.R., Hockenbery D., Kanagawa O., and Korsmeyer S.J. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67 (1991) 879-888
66. Hasserjian R.P., Aster J.C., Davi F., Weinberg D.S., and Sklar J. Modulated expression of notch1 during thymocyte development. Blood 88 (1996) 970-976
67. Deftos M.L., He Y.W., Ojala E.W., and Bevan M.J. Correlating notch signaling with thymocyte maturation. Immunity 9 (1998) 777-786
68. Kong F.K., Chen C.L., and Cooper M.D. Reversible disruption of thymic function by steroid treatment. J Immunol 168 (2002) 6500-6505
69. Moore M.J. Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacokinet 20 (1991) 194-208
70. + regulatory T cells in the steady state. J Exp Med 198 (2003) 737-746
71. Hori S., Haury M., Lafaille J.J., Demengeot J., and Coutinho A. Peripheral expansion of thymus-derived regulatory cells in anti-myelin basic protein T cell receptor transgenic mice. Eur J Immunol 32 (2002) 3729-3735
72. Caramalho I., Lopes-Carvalho T., Ostler D., Zelenay S., Haury M., and Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 197 (2003) 403-411
73. Dai J., Liu B., Ngoi S.M., Sun S., Vella A.T., and Li Z. TLR4 hyperresponsiveness via cell surface expression of heat shock protein gp96 potentiates suppressive function of regulatory T cells. J Immunol 178 (2007) 3219-3225
74. - CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc Natl Acad Sci U S A 102 (2005) 4091-4096
75. Contreras G., Pardo V., Leclercq B., Lenz O., Tozman E., O'Nan P., et al. Sequential therapies for proliferative lupus nephritis. N Engl J Med 350 (2004) 971-980
76. Ginzler E.M., Dooley M.A., Aranow C., Kim M.Y., Buyon J., Merrill J.T., et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 353 (2005) 2219-2228